TY - JOUR
T1 - Subjective experience of recovery from schizophrenia-related disorders and atypical antipsychotics
AU - Jenkins, Janis H.
AU - Strauss, Milton E.
AU - Carpenter, Elizabeth A.
AU - Miller, Dawn
AU - Floersch, Jerry
AU - Sajatovic, Martha
PY - 2005/9
Y1 - 2005/9
N2 - Aims: This article investigates the subjective experience of the process of improvement and recovery from the point of view of persons diagnosed (according to research diagnostic criteria) with schizophrenia and schizo-affective disorders. Methods: A community study of persons using psychiatric services was conducted for a sample of ninety subjects taking atypical antipsychotic medications. Sociodemographic data and clinical ratings were collected to complement the qualitatively developed Subjective Experience of Medication Interview (SEMI), which elicits narrative data on everyday activities, medication and treatment, management of symptoms, expectations concerning recovery, stigma, and quality of life. Results: Recovery was observed through: (1) relatively low ratings of psychiatrically observed symptomatology through BPRS scores; (2) the subjective sense among the majority (77.4%) of participants that taking medication plays a critical role in managing symptoms and avoiding hospitalization; and (3) the subjective sense articulated by the vast majority (80%) that they would recover from their illness and that the quality of their lives would improve (70.6%). Conclusion: The overall quality of improvement and recovery is best characterized as an incremental, yet definitively discernable, subjective process.
AB - Aims: This article investigates the subjective experience of the process of improvement and recovery from the point of view of persons diagnosed (according to research diagnostic criteria) with schizophrenia and schizo-affective disorders. Methods: A community study of persons using psychiatric services was conducted for a sample of ninety subjects taking atypical antipsychotic medications. Sociodemographic data and clinical ratings were collected to complement the qualitatively developed Subjective Experience of Medication Interview (SEMI), which elicits narrative data on everyday activities, medication and treatment, management of symptoms, expectations concerning recovery, stigma, and quality of life. Results: Recovery was observed through: (1) relatively low ratings of psychiatrically observed symptomatology through BPRS scores; (2) the subjective sense among the majority (77.4%) of participants that taking medication plays a critical role in managing symptoms and avoiding hospitalization; and (3) the subjective sense articulated by the vast majority (80%) that they would recover from their illness and that the quality of their lives would improve (70.6%). Conclusion: The overall quality of improvement and recovery is best characterized as an incremental, yet definitively discernable, subjective process.
UR - http://www.scopus.com/inward/record.url?scp=27144498589&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27144498589&partnerID=8YFLogxK
U2 - 10.1177/0020764005056986
DO - 10.1177/0020764005056986
M3 - Article
C2 - 16252790
AN - SCOPUS:27144498589
VL - 51
SP - 211
EP - 227
JO - International Journal of Social Psychiatry
JF - International Journal of Social Psychiatry
SN - 0020-7640
IS - 3
ER -